Charles Schwab Investment Management Inc Atri Cure, Inc. Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Atri Cure, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 392,861 shares of ATRC stock, worth $14.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
392,861
Previous 399,428
1.64%
Holding current value
$14.7 Million
Previous $12.2 Million
3.83%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding ATRC
# of Institutions
233Shares Held
51.5MCall Options Held
32.6KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.71MShares$177 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$173 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.68MShares$138 Million0.05% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3MShares$113 Million1.84% of portfolio
-
Macquarie Group LTD Australia, C32.44MShares$91.5 Million0.1% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.74B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...